Please Find Enclosed Herewith the Revised Annual Report for the Financial Year 2024-25 of the Company.

Boston Bio Systems Limited has submitted a revised Annual Report for FY 2024-25 to BSE, stating the earlier version had formatting issues. The revised report includes the AGM notice covering several major items: a proposed name change to 'Boston Commerce Limited', a sweeping change in the company's objects clause to enter IT/software, agriculture, real estate, and e-commerce/trading (moving away from its bio systems identity), and adoption of new MOA and AOA. The company is also seeking shareholder approval to raise the borrowing limit to Rs. 50 crore and to authorize loans, guarantees, and investments up to Rs. 50 crore under Section 186. The statutory auditor M/s Nahar V. & Co resigned, creating a casual vacancy now proposed to be filled by M/s Sunit M Chhatbar & Co, who are also being appointed for a 5-year term.